BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25023966)

  • 1. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
    Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
    J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
    Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
    Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.
    He Z; Liao Z; Chen S; Li B; Yu Z; Luo G; Yang L; Zeng C; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e259-e265. PubMed ID: 29749698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia.
    Huang X; Chen S; Shen Q; Yang L; Li B; Zhong L; Geng S; Du X; Li Y
    J Hematol Oncol; 2010 Nov; 3(1):44. PubMed ID: 21080944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
    Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q
    Front Immunol; 2022; 13():985280. PubMed ID: 36211334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
    Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
    Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles in BCL11B-siRNA treated malignant T cells.
    Huang X; Shen Q; Chen S; Chen S; Yang L; Weng J; Du X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
    J Hematol Oncol; 2011 May; 4():23. PubMed ID: 21575156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
    Fang H; Wang W; El Hussein S; Morita K; Beird HC; Mitra A; Loghavi S; Lin P; Jabbour EJ; Khoury JD
    Br J Haematol; 2021 Sep; 194(6):1034-1038. PubMed ID: 34402058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.
    Heesch S; Goekbuget N; Stroux A; Tanchez JO; Schlee C; Burmeister T; Schwartz S; Blau O; Keilholz U; Busse A; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
    Haematologica; 2010 Jun; 95(6):942-9. PubMed ID: 20435628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.
    Ha VL; Luong A; Li F; Casero D; Malvar J; Kim YM; Bhatia R; Crooks GM; Parekh C
    Leukemia; 2017 Nov; 31(11):2503-2514. PubMed ID: 28232744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL11B is frequently downregulated in HTLV-1-infected T-cells through Tax-mediated proteasomal degradation.
    Permatasari HK; Nakahata S; Ichikawa T; Morishita K
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1086-1092. PubMed ID: 28669733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.
    Kraszewska MD; Dawidowska M; Kosmalska M; Sędek L; Grzeszczak W; Kowalczyk JR; Szczepański T; Witt M;
    Blood Cells Mol Dis; 2013 Jan; 50(1):33-8. PubMed ID: 23040356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.
    Huang X; Chen S; Shen Q; Chen S; Yang L; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
    Hematology; 2011 Jul; 16(4):236-42. PubMed ID: 21756541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.
    Chen C; Huang L; Liu S; Jiang X; Chen F; Wei X; Guo H; Zeng X; Zeng C; Przybylski GK; Li W; Li Y
    Asia Pac J Clin Oncol; 2024 Feb; 20(1):81-86. PubMed ID: 37635422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
    Ehrlich LA; Yang-Iott K; Bassing CH
    Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
    Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study.
    Cleaver AL; Beesley AH; Firth MJ; Sturges NC; O'Leary RA; Hunger SP; Baker DL; Kees UR
    Mol Cancer; 2010 May; 9():105. PubMed ID: 20459861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Inducible
    Przybylski GK; Korsak D; Iżykowska K; Nowicka K; Zalewski T; Tubacka M; Mosor M; Januszkiewicz-Lewandowska D; Frydrychowicz M; Boruczkowski M; Dworacki G; van den Brandt J; Grabarczyk P; Schmidt CA; Zeng C; Li Y
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.